Since type I IFNs are frequent participants in TME and most cancer cells express their receptors, induction of SERPINB9 should be a more plausible mechanism underlying the evasion of tumor cells from GrB-dependent proteolysis (145). The gene discussed is SERPINB9; the disease is cancer.